Skip to main content
TipRanks
Go Ultimate75% OFF

Yuyu Pharma, Inc. (000220) Stock Statistics & Valuation Metrics

Total Valuation

Yuyu Pharma, Inc. has a market cap or net worth of KRW 54.09B. The enterprise value is KRW 76.23B.

Market Cap
KRW 54.09B
Enterprise Value
KRW 76.23B

Share Statistics

Yuyu Pharma, Inc. has 15,747,462 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
15,747,462
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Yuyu Pharma, Inc.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 6.02%.

Return on Equity (ROE)
0.06
Return on Assets (ROA)
0.04
Return on Invested Capital (ROIC)
6.02%
Return on Capital Employed (ROCE)
0.07
Revenue Per Employee
568.08M
Profits Per Employee
32.88M
Employee Count
248
Asset Turnover
0.68
Inventory Turnover
2.06

Valuation Ratios

The current PE Ratio of Yuyu Pharma, Inc. is 5.34. Yuyu Pharma, Inc.’s PEG ratio is 0.06.

PE Ratio
5.34
PS Ratio
0.41
PB Ratio
0.43
Price to FCF
15.03
Price to Operating Cash Flow
2.41
PEG Ratio
0.06

Income Statement

In the last 12 months, Yuyu Pharma, Inc. had revenue of 140.88B and earned 8.15B in profits. Earnings per share was 492.00.

Revenue
140.88B
Gross Profit
53.94B
Operating Income
11.02B
Pretax Income
9.48B
Net Income
8.15B
EBITDA
16.63B
Earnings Per Share (EPS)
492.00

Cash Flow

In the last 12 months, operating cash flow was 24.19B and capital expenditures -20.30B, giving a free cash flow of 3.88B billion.

Operating Cash Flow
24.19B
Free Cash Flow
3.88B
Free Cash Flow per Share
246.45

Dividends & Yields

Yuyu Pharma, Inc. pays an annual dividend of ―, resulting in a dividend yield of 3.10%

Dividend Per Share
―
Dividend Yield
3.10%
Payout Ratio
N/A
Free Cash Flow Yield
6.65%
Earnings Yield
19.48%

Stock Price Statistics

Beta
0.11
52-Week Price Change
-12.10%
50-Day Moving Average
3750.40
200-Day Moving Average
3945.78
Relative Strength Index (RSI)
46.49
Average Volume (3m)
106.06K

Important Dates

Yuyu Pharma, Inc. upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 24, 2027
Ex-Dividend Date
―

Financial Position

Yuyu Pharma, Inc. as a current ratio of 1.64, with Debt / Equity ratio of 21.60%

Current Ratio
1.64
Quick Ratio
0.93
Debt to Market Cap
0.36
Net Debt to EBITDA
-0.07
Interest Coverage Ratio
1.98

Taxes

In the past 12 months, Yuyu Pharma, Inc. has paid 365.96M in taxes.

Income Tax
365.96M
Effective Tax Rate
0.04

Enterprise Valuation

Yuyu Pharma, Inc. EV to EBITDA ratio is 8.72, with an EV/FCF ratio of 16.96.

EV to Sales
0.46
EV to EBITDA
8.72
EV to Free Cash Flow
16.96
EV to Operating Cash Flow
2.72

Balance Sheet

Yuyu Pharma, Inc. has KRW 30.03B in cash and marketable securities with KRW 34.47B in debt, giving a net cash position of -KRW 4.44B billion.

Cash & Marketable Securities
KRW 30.03B
Total Debt
KRW 34.47B
Net Cash
-KRW 4.44B
Net Cash Per Share
-KRW 282.15
Tangible Book Value Per Share
KRW 9,245.18

Margins

Gross margin is 37.73%, with operating margin of 7.97%, and net profit margin of 7.92%.

Gross Margin
37.73%
Operating Margin
7.97%
Pretax Margin
7.69%
Net Profit Margin
7.92%
EBITDA Margin
5.26%
EBIT Margin
1.29%

Analyst Forecast

The average price target for Yuyu Pharma, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
2.90%
EPS Growth Forecast
128.65%

Scores

Smart Score
―
AI Score
67